All information regarding prescription drugs on this site is intended only for doctors or pharmacists or nurses, authorized by local and national authorities to engage in their professions.

Kamada Ltd. is not responsible for any use made with this information, and use of it shall be the sole responsibility of the user.

   
KAMADA » PRODUCTS » LUNG DISEASE » BRAMITOB

BRAMITOB

Indications:

Management of chronic pulmonary infection due to Pseudomonas aeruginosa in patients of 6 years and older with cystic fibrosis.

Active Ingredient: Tobramycin
Strength: 300 mg
Volume: 4 ml
Method of Administration: Solution for administration by inhalation

Product photo